I am a
Home I AM A Search Login

Papers of the Week


Front Oncol


Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-Analysis.


Jin Y, Wei J, Weng Y, Feng J, Xu Z, Wang P, Cui X, Chen X, Wang J, Peng M
Front Oncol. 2022; 12:732814.
PMID: 35280727.


Immune checkpoint inhibitors (ICIs) have made a breakthrough in the systemic treatment of patients with advanced tumors. However, little is known about their efficacy and safety in adjuvant settings after the resection of solid tumors.